BRAINSTORM CELL THERAPEUTICS INC.·4

Jul 17, 5:01 PM ET

ARBEL IRIT 4

4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jul 17, 2017

Insider Transaction Report

Form 4
Period: 2017-07-13
ARBEL IRIT
Director
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-13+12,00012,000 total
    Exercise: $0.75From: 2018-07-13Exp: 2028-07-13Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]Option is fully vested and exercisable on the date of grant.

Documents

1 file
  • 4
    v470752_4.xmlPrimary

    OWNERSHIP DOCUMENT